SCHEMBL10106332

SCHEMBL10106332

C=C(C)C(=O)OCCOC(=O)NCCCCCCNC(=O)N(CCCCCCNC(=O)OCCOC(=O)C(=C)C)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.41
THRB P10828 1/20 0.40
TSHR P16473 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383541 0.90 ACHE (0.44) ACHETHRBTSHR
SCHEMBL10331942 0.84 ACHE (0.54) ACHETHRBTSHR
SCHEMBL10060076 0.81 THRB (0.44) THRBTSHR
SCHEMBL19884887 0.81 ACHE (0.56) ACHETHRBTSHR
SCHEMBL275242 0.81 ACHE (0.56) ACHETHRBTSHR
SCHEMBL13872032 0.79 ACHE (0.58) ACHETHRBTSHR
SCHEMBL12054364 0.79 ACHE (0.38) ACHETSHR
SCHEMBL15159467 0.78 EPHX1 (0.46) TSHR
SCHEMBL18094783 0.78 TSHR (0.65) ACHETSHR
SCHEMBL17225744 0.78 TSHR (0.60) ACHETHRBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079828-B2 Polymerizable compounds comprising a polyalicylic structure element VOCO GMBH (DE) 2015-07-14 US disclosed
US-9079828-B2 Polymerizable compounds comprising a polyalicylic structure element VOCO GMBH (DE) 2015-07-14 US disclosed
US-20120082959-A1 Polymerizable Compounds Comprising a Polyalicylic Structure Element VOCO GMBH (DE) 2012-04-05 US disclosed
US-20120082959-A1 Polymerizable Compounds Comprising a Polyalicylic Structure Element VOCO GMBH (DE) 2012-04-05 US disclosed
EP-2436668-A1 Polymerisable compounds comprising a polyalicyclic structure element VOCO GmbH (DE) 2012-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120082959-A1 Polymerizable Compounds Comprising a Polyalicylic Structure Element PCBP1, PUF60, PARG ACHE 3769/4885THRB 4037/4885TSHR 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.